University of Granada - Instituto Mixto Universitario Deporte y Salud
Granada, 18011, Spain
NCT Number: NCT05369715
The main objective of this project is to study the diurnal variation of the effect of exercise on glycemic metabolism and fat oxidation in humans.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
Granada, 18011, Spain
Strong scientific evidence supports the beneficial effects of exercise on cardiovascular health, the regulation of glucose metabolism, and fat oxidation. Physical performance capacity is known to fluctuate throughout the day, however, it is unknown whether there is an optimal time of day to maximize the effects of exercise on health, and specifically on blood glucose metabolism and fat oxidation. Finding the ideal time to perform physical exercise is of clinical and public health interest. Likewise, optimizing the timing of physical exercise to coincide with the greater physiological response of each individual would mean increasing the potential of exercise as a therapeutic tool.
Specific aims of this project are a) to describe possible differences dependent on sex in the diurnal variation of the effect of exercise on glycemic metabolism and fat oxidation, and b) to characterize the molecular mechanisms implicated.
18 men and 17 women with normal weight will be randomized into two conditions (morning and evening) with at least 3 days of separation in between. Each evaluation will conform the following tests:
Previous to this, participants' body composition and fitness level will be assesed via densitometry and a maximal exercise test, respectively.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Aerobic exercise
Time frame: 4 days. Pre exercise day, exercise day, post-24hrs exercise day, post-48hrs exercise day.
A continuous glucose monitor inserted into the skin of the arm upper forearm area will be used to record and store blood glucose levels every 15 minutes, for 24 hours, 14 consecutive days. Within this time range both exercise conditions will be performed. The monitor will be placed 24 hours before the first exercise session and will be removed 48 hours after the second exercise session. Therefore, change from resting blood glucose 24 hours previous to 48 hours after exercise will be obtained for each condition.
Time frame: 210 minutes
Participants will lay down for 60 minutes where resting gas exchange was measured (using a canopy hood for gases collection) for 30 minutes in two separated 15 minutes stages, corresponding to 45 to 60 and 75 to 90 minutes after exercise, respectively
Time frame: 180 minutes
Blood samples will be taken after exercise, immediately after exercise and 90 minutes after exercise, in order to measure change in plasma concentration of markers of glucose metabolism from resting to 90 minutes after exercise.
Time frame: 180 minutes
Blood samples will be taken to measure plasma concentration of markers of fatty acid metabolism before, immediately after and 90 minutes after exercise.
Time frame: 90 minutes
Muscular biopsies will be taken from the vastus lateralis' distal part of the quadriceps in a sub-sample before and immediately after the exercise. Biopsies will be performed by an experienced surgeon using microbiopsy needles (Achieve Automatic Needle 16G x 15 cm), obtaining ~30 mg per biopsy after previous local anaesthesia with 2% lidocaine. From each time point (Pre and Post), 1 skeletal muscle samples will be collected and immersed in liquid nitrogen and stored at -80ºC until further analysis (i.e.: transcriptomics). RNA from skeletal muscle will be extracted using Trizol (Invitrogen).
Time frame: 90 minutes
Muscular biopsies will be taken from the vastus lateralis' distal part of the quadriceps in a sub-sample before and immediately after the exercise. Biopsies will be performed by an experienced surgeon using microbiopsy needles (Achieve Automatic Needle 16G x 15 cm), obtaining ~30 mg per biopsy after previous local anaesthesia with 2% lidocaine. From each time point (Pre and Post), 1 skeletal muscle samples will be collected and immersed in liquid nitrogen and stored at -80ºC until further analysis (i.e.: proteomics).
Time frame: 90 minutes
Muscular biopsies will be taken from the vastus lateralis' distal part of the quadriceps in a sub-sample before and immediately after the exercise. Biopsies will be performed by an experienced surgeon using microbiopsy needles (Achieve Automatic Needle 16G x 15 cm), obtaining ~30 mg per biopsy after previous local anaesthesia with 2% lidocaine. From each time point (Pre and Post), 1 skeletal muscle samples will be collected and treated fresh to study mitochondrial respiration.
Time frame: 90 minutes
Muscular biopsies will be taken from the vastus lateralis' distal part of the quadriceps in a sub-sample before and immediately after the exercise. Biopsies will be performed by an experienced surgeon using microbiopsy needles (Achieve Automatic Needle 16G x 15 cm), obtaining ~30 mg per biopsy after previous local anaesthesia with 2% lidocaine. From each time point (Pre and Post), 1 skeletal muscle samples will be collected and immersed in liquid nitrogen and stored at -80ºC until further analysis (i.e.: mitochondrial protein supercomplexes by blue-native PAGE).
Time frame: 180 minutes
Measures of appetite before, immediately after and 90 minutes after exercise using an appetite visual analog scale (appetite VAS) scoring from 0 to 10, where 0 is the minimum punctuation for appetite and 10 is the maximum punctuation for appetite.
Time frame: 255
Before, during and after exercise, periodic recordings of the central and distal temperature will also be made by using thermal iButtons (iButtons DS 1922 L, Maxim, Dallas, USA).
Time frame: 4 days. Pre-exercise day, exercise day, post-24 hrs exercise and post-48 hrs exercise
Standarditation and control of diet. Diet will be standardized 24 hours prior to each exercise session (55% carbohydrates, 27% fat and 18% proteins). In addition, diet will be monitored for 48 hours after the exercise test.
Time frame: 4 days. Pre-exercise day, exercise day, post-24 hrs exercise and post-48 hrs exercise
Levels of physical activity will be controlled by accelerometry 24 hours before and 48 hours after each exercise session (Actigraph, GT3X).
Time frame: 7 minutes
Body fat percentage will be evaluated by dual X-ray absorptiometry (Discovery Wi, Hologic, Inc, Bedford, MA, USA).
Time frame: 5 minutes
Weight and height will be measured (Seca model 799, Electronic Column Scale, Hamburg, Germany). Weight and height measurements will be aggregated to obtain BMI in kg/m^2
Time frame: 15 minutes
Participants will complete the HÖME questionnaire, that determines chronotype (morning-evening).
Time frame: 5 minutes
Dates of the different phases of the menstrual cycle will be recorded in order to locate all tests in the luteal phase. However, we have observed that fat oxidation is not affected by the phase of the menstrual cycle
Universidad de Granada
Other
Diurnal Variation of the Effect of Aerobic Exercise on Glycemic Metabolism and Fat Oxidation in Humans: Role of Sex
Acronym: DIVA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06217068
Acute Exercise, Aerobic Exercise
Athens, Georgia, United States
View Trial DetailsNCT07058584
Aerobic Exercise, Repetitive Transcranial Magnetic Stimulation (rTMS)
Gistrup, Denmark
View Trial DetailsNCT07471646
Aerobic Exercise, Body Weight
Ann Arbor, Michigan, United States
View Trial DetailsNCT06617637
Abnormalities, Multiple, Aerobic Exercise
Istanbul, Eyüpsultan, Turkey (Türkiye)
View Trial Details